KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Staar Surgical (STAA) Revenue (2016 - 2026)

Staar Surgical's Revenue history spans 17 years, with the latest figure at $57.8 million for Q1 2026.

  • For Q1 2026, Revenue rose 18.08% year-over-year to $57.8 million; the TTM value through Jan 2026 reached $239.4 million, down 23.72%, while the annual FY2026 figure was $239.4 million, 23.72% down from the prior year.
  • Revenue reached $57.8 million in Q1 2026 per STAA's latest filing, down from $94.7 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $99.0 million in Q2 2024 to a low of $19.1 million in Q4 2022.
  • Average Revenue over 5 years is $69.7 million, with a median of $76.2 million recorded in 2022.
  • Peak YoY movement for Revenue: tumbled 67.64% in 2022, then surged 299.44% in 2023.
  • A 5-year view of Revenue shows it stood at $19.1 million in 2022, then soared by 299.44% to $76.3 million in 2023, then crashed by 35.82% to $48.9 million in 2024, then surged by 93.53% to $94.7 million in 2025, then crashed by 38.98% to $57.8 million in 2026.
  • Per Business Quant, the three most recent readings for STAA's Revenue are $57.8 million (Q1 2026), $94.7 million (Q3 2025), and $44.3 million (Q2 2025).